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DNAdamage is an important initiator of neuronal apoptosis and activates signaling events not yet fully defined.Using the camptothecin-
induced DNA damage model in neurons, we previously showed that cyclin D1-associated cell cycle cyclin-dependent kinases (Cdks)
(Cdk4/6) andp53 activation are twomajor events leading to activation of themitochondrial apoptotic pathway.With gene array analyses,
we detected upregulation of Cited2, a CBP (cAMP response element-binding protein-binding protein)/p300 interacting transactivator, in
response to DNA damage. This upregulation was confirmed by reverse transcription-PCR and Western blot. CITED2 was functionally
important because CITED2 overexpression promotes death, whereas CITED2 deficiency protects. Cited2 upregulation is upstreamof the
mitochondrial death pathway (BAX, Apaf1, or cytochrome c release) and appears to be independent of p53. However, inhibition of the
Cdk4 blocked Cited2 induction. The Cited2 prodeath mechanism does not involve Bmi-1 or p53. Instead, Cited2 activates peroxisome
proliferator-activated receptor- (PPAR), an activity that we demonstrate is critical for DNA damage-induced death. These results
define a novel neuronal prodeath pathway in which Cdk4-mediated regulation of Cited2 activates PPAR and consequently caspase.
Key words: Cited2; PPAR; Cdk4; DNA damage; cortical neurons; camptothecin
Introduction
DNA damage in neurons is acknowledged as an important com-
ponent of neuronal disease and injury. The pathways that regu-
late neuronal DNA damage-induced death converge on the clas-
sical intrinsic apoptotic pathway. For example, we showed that
death induced by the DNA-damaging agent camptothecin, a to-
poisomerase I inhibitor, is mediated by BAX translocation to
mitochondria, cytochrome c (cyt c) release, and caspase-3 activa-
tion (Stefanis et al., 1999; Keramaris et al., 2000).
Several major proapoptotic signals have been shown to pre-
cede this conserved mitochondrial pathway of death after DNA
damage. For example, p53 regulates death, at least in part, by
modulating prodeath Bcl2 members such as Puma (Keramaris et
al., 2003; Sedarous et al., 2003; Aleyasin et al., 2004; Cregan et al.,
2004).
Another signal, regulated independent of p53, is the activation
of abnormal cell cycle signals. Accumulating evidence indicates
that inappropriate activation of cell cycle cyclin-dependent ki-
nases (Cdks) lead to neuronal death. For example, we previously
showed that cyclin D1/Cdk4 is activated and required for death
after-amyloid toxicity, delayed ischemic insult, andDNA dam-
age (Park et al., 1998; Giovanni et al., 2000; Ghahremani et al.,
2002; Rashidian et al., 2005). The manner by which this occurs is
not completely clear. In models of DNA damage, we showed that
cyclinD1/Cdk4 activation is regulated by aChk1/cdc25a pathway
(Zhang et al., 2006). Cdk4 then phosphorylates the tumor sup-
pressor retinoblastoma (Rb) protein leading to E2F transactiva-
tion (Park et al., 1998, 2000). Although these findings provide a
skeletal structure to death regulation induced by cell cycle signal-
ing and DNA damage, additional players are likely involved.
To this end, we undertook a gene array study to examine for
differentially expressed genes from embryonic cortical neurons
exposed to camptothecin (campto) (our unpublished data). One
of the genes significantly upregulated was Cited2, a CBP (cAMP
response element-binding protein-binding protein)/p300 inter-
acting transactivator. Cited2 was first identified as a transcrip-
tional coactivator expressed in the nucleus (Bhattacharya et al.,
1999). Cited2 has a critical role in development and its deficiency
is embryonic lethal. Knock-out (KO) embryos exhibit cardiac
malformations, adrenal agenesis, neural crest defects, and exen-
cephaly (Bamforth et al., 2001). Cited2 is also a target/negative
regulator of hypoxia-inducible factor (HIF) (Bhattacharya et al.,
1999; Freedman et al., 2003). Additionally, Cited2 promotes pro-
liferation at least in part via activation of expression of the
polycomb-group genes Bmi-1 (Kranc et al., 2003), negative reg-
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ulator of the ink4a-ARF locus. Finally, Cited2 can act as a ligand
independent activator of peroxisome proliferator-activated re-
ceptors (PPARs)  and  (Tien et al., 2004). PPARs are nuclear
receptors with transcriptional activity that have been implicated
in awide range of biological processes including cell growth, lipid
homeostasis, angiogenesis, and neuronal apoptosis.
The main goal of this research project, then, was to elucidate
the role andmechanismof action of Cited2 in neuronal apoptosis
induced by DNA damage. We show that Cited2 is part of the cell
cycle pathway and acts to promote death through activation of
PPAR. This defines a novel pathway by which abnormal cell
cycle activation regulates neuronal death.
Materials andMethods
Primary cultures and drug treatments. Cortical neurons were dissected
from embryonic day 14 (E14) to E15 mouse embryos, plated at 1.25–
1.8  106 cells/ml, and cultured in supplemented Neurobasal media
(Invitrogen) at 37°C and 5% CO2. After 2–4 d in vitro (DIV), cells were
treated with 1 or 10 M camptothecin and/or CDK inhibitor [1 M
flavopiridol (Stefanis et al., 1999)], caspase inhibitor [50 M Boc-
Asp(OMe)-fluoromethyl ketone (BAF) (Keramaris et al., 2000)], mixed
lineage kinase (MLK) inhibitor [200 nM CEP11004 (Ghahremani et al.,
2002)], PPAR inhibitor [10–30 M 2-chloro-5-nitrobenzanilide
(GW9662) (Leesnitzer et al., 2002)], or PPAR agonist [20–50 M cigli-
tazone (Willson et al., 1996)].
Transgenic mice. All transgenic mice used were in a C57BL/6J back-
ground. Cortical neurons from each embryo derived from heterozygous
crosses were dissected and plated individually. Embryos were genotyped
by PCR using specific primers for wild-type (WT) and KO alleles. Em-
bryos from Cited2 crosses were genotyped using the following primers
and program: 247 bp WT product: upper, 5-aaaggcgctaaggatagacac-3;
lower, 5-atactgaggtccctggcac-3; 372 bp KO product: upper, 5-ctacccg-
gtagaattgacctg-3; lower, 5-tgctgtaagaccttcttggc-3; PCR program: 94°C
for 10min; 15 cycles of 95°C for 30 s, 30 s 67.5–0.5°C/cycle, 72°C for 45 s;
15 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 45 s. This was
followed by 72°C for 10min. Embryos from p53, BAX, and Apaf-1 trans-
genicmice crosses were genotyped as previously described (Cregan et al.,
1999; Fortin et al., 2001; Aleyasin et al., 2004).
Semiquantitative reverse transcription-PCR. Total RNA was extracted/
purified using TriPure isolation reagent (Trizol) per the manufacturer’s
protocols (Invitrogen). Fifty nanograms of total RNA were used for the
cDNA synthesis and gene amplification reactions using SuperScript
One-Step with Platinum Taq from Invitrogen. cDNA synthesis was per-
formed at 48°C for 45 min, followed by a 2 min initial denaturation step
at 94°C. This was followed by 30 cycles (Noxa, HIF1-, cyt c), 26 cycles
(PUMA), or 25 cycles (Cited2, PPAR, Bmi-1, S12) at 94°C for 30 s,
melting temperature (Tm) (°C) for 30 s, and 72°C for 1 min. Targeting
primers were as follows: for Cited2, 5-tagggcagcggaggaaaagaa-3 and
5-ccctcgccgtagtgtatgtgctc-3 (Tm, 60°C); for Bmi-1, 5-agagcagattg-
gatcggaaa-3 and 5-gactgggcaaacaggaagag-3 (Tm, 58°C); for PPAR,
5-aggcgagggcgatcttgacag-3 and 5-agggcttccgcaggtttttgag-3 (Tm, 57°C);
for PUMA, 5-cctcagccctccctgtcaccag-3 and 5-ccgccgctcgtactgcgcgttg-3
(Tm, 55°C); for HIF1-, 5-tgctcatcagttgccacttc-3 and 5-cttccacgtt-
gctgacttga-3 (Tm, 59°C); for cytochrome c, 5-ccaaatctccacggtctgtt-3 and
5-gtctgccctttctcccttct-3 (Tm, 59°C). Products were resolved on a 2% aga-
rose (Invitrogen)–ethidium bromide gel, and correct band for Cited2,
Bmi-1, PPAR, HIF1-, and cyt c were processed by densitometry. Tran-
script levelswere normalized against S12 signals and resultswere reported as
times fold increase in reference to control values (untreated control for each
individual experiment) or as relative mRNA level (normalized value). Data
are presented as mean SEM of at least three independent experiments.
Quantitative reverse transcription-PCR. Twenty nanograms of RNA
was used in one-step SYBR green reverse transcription (RT)-PCR as per
manufacturer’s instructions (QuantiTect; QIAGEN). RT-PCR was per-
formed on a Chromo4 system (MJ Research/Bio-Rad) and changes in
Cited2 mRNA were determined by the (Ct) method using S12 tran-
script for normalization. PCRs exhibited high amplification efficiency
(90%) and the specificity of PCR products was confirmed by sequenc-
ing. Data are reported as fold increase in mRNA levels in campto-treated
samples relative to corresponding untreated control cells and expressed
as mean SEM (n 4 for each genotype).
SDS-PAGE and Western analysis. Cells were harvested after wash with
cold PBS by scraping in 62.5mMTris-HCl, 2%w/v SDS, 10% glycerol, 50
mM dithiothrietol, and 0.1%w/v bromophenol blue, heated at 95–100°C
for 5min, and then resolved on 7.5, 10, or 20% SDS-PAGE. Transference
was done to polyvinylidene difluoride membranes (PolyScreen;
PerkinElmer Life and Analytical Sciences) that were then incubated in
1% casein–Tris-buffered saline (TBS) for blocking. Primary antibodies
were diluted in 5% bovine serum albumin (BSA)/TBS as follows: anti-
CITED2, 1:500 (Novus Biologicals; JA22); anti-PPAR, 1:200 (Santa
Cruz; H-100:sc-7196); anti--actin, 1:3000 (Sigma-Aldrich); anti-
cytochrome c, 1:2000 (BD Biosciences Pharmingen); anti-OxPhos-
complex I subunit, 1:1000 (Invitrogen); anti-PPAR, 1:150 (Santa
Cruz); and anti-HIF1-, 1:500 (Cayman Chemical). Secondary antibod-
ies [goat anti-mouse or anti-rabbit IgG(H_L)HRP conjugate (Bio-Rad)]
were all used at 1:3000 in 3% BSA in 136 mM NaCl, 2.68 mM KCl, 10.14
mM Na2HPO4, 1.76 mM KH2PO4, pH 7.4, and 0.1% Tween 20 (PBS/T).
Immunoreactivity was detected using Western blot chemiluminescence
reagent system (PerkinElmer Life and Analytical Sciences). Results were
processed by densitometry. Protein levels were normalized against
-actin signals, and results were reported as times fold increase in refer-
ence to control values (untreated control for each individual experi-
ments) or as relative protein level (normalized value). Data are presented
as mean SEM of at least three independent experiments.
Transient transfection by calcium phosphate. Seventy-two to 96 h after
plating, cortical neurons were transiently transfected using calcium
phosphate coprecipitation protocol as described previously (Xia et al.,
1996; Zhang et al., 2006). Cortical neurons were cotransfected with cy-
tomegalovirus (CMV) promoter-driven green fluorescent protein
(GFP)-expressing plasmid (3 g) and an empty vector (pcDNA3) or
Cited2-expressing vector (6 g), generously donated by Dr. Shoumo
Bhattacharya (TheWellcomeTrust Centre forHumanGenetics, Oxford,
UK). Twenty-four hours after transfection,DNAdamagewas induced by
adding 10 M campto and cells were incubated for 21 h. Cells were then
fixed in 4% paraformaldehyde, 125 mM sodium dihydrogen phosphate,
125mMdisodiumhydrogen phosphate, and 14%picric acid for 30min at
room temperature and washed with PBS. Transfected cells were identi-
fied by green fluorescence and integrity of the nucleus was analyzed by
0.25 g/ml Hoechst 33342 staining (10 min at room temperature; Sigma-
Aldrich). At least 250 GFP-positive cells per treatment were counted.
Percentage survival was calculated as GFP-expressing live/GFP-
expressing total number of neurons. Results are presented as mean 
SEM of three replicas per treatment.
Transient transfection with Lipofectamine. Neuronal cultures were
transfected using Lipofectamine 2000 (Invitrogen) at a ratio of 1.3 g of
DNA to 1 l of Lipofectamine/well. Briefly, neurons were cotransfected
with 0.3 g of reporter vector (CMV promoter-driven GFP-expressing
plasmid) and 1.0 g of empty (pcDNA3), Cited2-, or DNPPAR-
expressing vector [generously donated by Dr. Shoumo Bhattacharya and
Dr. V. Krishna K. Chatterjee (Institute ofMetabolic Science, Cambridge,
UK), respectively]. Twenty-four hours after transfection, cells were
treated with 10 M campto, 20 M GW9662, 40 M ciglitazone, alone or
in specified combinations, and incubated for 21 h. Cells were then fixed
and processed accordingly.
Viral infection.Adenoassociated virus (AAV) expressing a kinase-dead
[dominant-negative (DN)] form of Cdk4 was obtained as previously
described (Rashidian et al., 2005). Cortical neurons were exposed to 150
multiplicity of infection (MOI) units of AAV at the time of plating. Six to
7 DIV after infection, cells were exposed to campto as described above,
and total mRNA or protein was extracted. Samples were used to detect
Cited2 levels by RT-PCR and Western blot as previously stated.
Cell survival assessment. Cells were lysed in 150 l of cell lysis buffer
(0.1 PBS, pH 7.4, 0.5% Triton X-100, 2 mM MgCl2, 0.5% cetylmethyl-
ammonium bromide). Nuclei were evaluated under phase microscopy
and healthy ones were counted (at least 150 nuclei for nontreated control
wells). Percentage survival was calculated as the remaining number of
live nuclei in campto-treated (12, 16, 20 h) compared with untreated
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control (0 h; 100%). Data are presented as mean SEM of at least three
independent experiments.
PPAR reporter experiments. TransLucent PPAR reporter vectors
from Panomics (LR0066) were used. Embryonic cortical neurons from
CD1WTmice or transgenic Cited2 littermates were used. Three days in
vitro after plating, cells were cotransfected with CMV--galactosidase-
and PPAR responsive element (PPRE)-luciferase-expressing plasmids
as described above for Lipofectamine transfection. Twenty-four hours
after, cells were then exposed to 10 M campto and or 1 M flavopiridol.
At 0–4 h after treatment, cells were collected and lysed with 130l of cell
culture lysis reagent (Promega). For coexpression of Cited2 and PPRE-
luciferase, transfection was made using 0.3 g of CMV--galactosidase
and 1 g of each Cited2- and PPRE-luciferase-expressing plasmids for a
total of 2.3 g of DNA/1 l of Lipofectamine. Samples were assayed in
triplicates for luciferase and -galactosidase activity as previously de-
scribed (Fortin et al., 2001). Luciferase activity signals were standardized
using -galactosidase activity values and results were presented either as
relative PPAR activity (luciferase/-galactosidase) or as fold increase in
reference to control values (untreated control for each individual exper-
iment, 0 h). Data are presented as mean  SEM of three independent
experiments.
Caspase activity. After 2 DIV, cells were treated with 10 M campto
and/or 20 M GW9662, as described above. Total protein was extracted
in 1 mM KCl, 10 mM HEPES, 1.5 mM MgCl2, 1 mM DTT, 1 mM PMSF,
10%glycerol, protease inhibitormixture (Roche) as described previously
(O’Hare et al., 2000). Each sample was analyzed in three replicas of 5 g
each. Protein was incubated with Z-DEVD-AFC (Invitrogen) in caspase
assay buffer [25 mM HEPES, 10 mM DTT, 10% sucrose, 0.1% CHAPS
(3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate), 15
MZ-DEVD-AFC] and fluorescence at 505 nmwasmeasured at different
time points (30 min to 2 h), using an excitation wavelength of 400 nm.
Readings weremade using a PerkinElmer Life and Analytical Sciences LS
50B Luminescence spectrometer with a slit width of 5 and 1 s integration
time. Fluorescence versus time was plotted for each replica and the slope
of the curve (linear regression) was used as cleavage activity value
(caspase activity). Data are presented as mean  SEM of four indepen-
dent experiments.
Cytochrome c inmmunocytochemistry. After 2 DIV, cortical neurons
from CD1WT embryos or littermate embryos derived from heterozy-
gous Cited2 mice crosses were treated with 10 M campto or/and 20
M GW9662 for 12 h, fixed as described above, and stained with cyt c
antibody (BD Biosciences Pharmingen), followed by Hoechst 33258
staining. At least 100 cells per replica were assessed by immunofluo-
rescence and neurons positive for punctate cyt c were counted. Data
are presented as percentage mitochondrial
cyt c (percentage of neurons positive for
punctate cyt c). The bars represent the
mean  SEM from three independent exper-
iments or embryos of each specified
genotype.
Immunoprecipitation. Cortical neurons
(20 106 cells) were harvested in lysis buffer
(50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM
EDTA, 1 mM DTT, and 0.2% NP-40) supple-
mented with protease inhibitors. Immunopre-
cipitations (IPs) were performed through incu-
bation of anti-Cited2 antibody (JA22) with
lysates overnight followed by incubation with
anti-mouse Ig IP beads (eBiosciences) at 4°C for
2 h. The beads were washed three times by lysis
buffer without protease inhibitors.
Results
Cited2 signals death of cortical neurons
after DNA damage
Our initial gene array screen suggested
that Cited2 might be upregulated after
DNA damage treatment. To test this, we
first determined whether Cited2 message
was upregulated after campto treatment byRT-PCR. As shown in
Figure 1A, induction of Cited2message was detectable as early as
2 h after initiation of camptothecin treatment and reached amax-
imum (4.5-fold) induction at 4 h.We next determinedwhether
an increase in message was also associated with increased protein
levels. Consistent with an increase in message, CITED2 protein
was also induced with an increase detectable as early as 2 h ( p
value, 0.036). Protein levels were still induced 8 h after DNA
damage treatment (Fig. 1B).
The early induction of Cited2 suggested it might be function-
ally relevant for death. This is particularly important because, in
this model, we have previously shown that the commitment
point for death occurs 6–8 h after treatment (Morris et al., 2001).
To test the functional importance of Cited2, we determined the
effect of Cited2 overexpression on neuronal survival either with
or without DNA damage insult. We first delivered Cited2 by
calcium phosphate transfection. Importantly, in this initial ex-
periment, there was more death in neurons expressing Cited2
when compared with GFP control either basally (42.4 vs 27.5%)
or with campto treatment (64 vs 48.1%) (Fig. 2A). To confirm
this, we subsequently performed three independent experiments
using Lipofectamine carrier. This was done to insure that any
results were not necessarily attributable to the delivery method.
We obtained similar results (Cited2 vs GFP, basally 37.2 vs
23.6%, or with campto treatment, 74.7 vs 55.8%) (see Fig. 6C).
This indicates that Cited2 is sufficient to induce death. To address
whether Cited2 was necessary for neuronal death, we cultured
cortical neurons from Cited2-deficient or heterozygous and WT
littermate controls. As shown in Figure 2B, the absence of Cited2
in neurons confers significant resistance to the genotoxic insult.
Deficiency by itself delays, but does not prevent, death. Together,
these results indicate that upregulated Cited2 contributes to
death of neurons after DNA damage.
DNA damage-Cited2 induction is upstream of the
mitochondrial death pathway but independent of p53
We next wanted to determine the factors that regulated Cited2
induction. The early induction of Cited2 suggested that its regu-
latory pathways would also act early. Indeed, we previously
showed caspase activation occurs later at6–8 h after initiation
Figure 1. Cited2 mRNA and protein levels are upregulated after DNA damage. Total mRNA or protein was extracted from
cortical neurons treated for different timeswith 10M campto and subjected to either RT-PCR (A) orWestern blot (B). Densitom-
etry of all signalswasperformedandCited2 signalwasnormalized to S12 (A) andactin (B), respectively. Data arepresentedas fold
increase relative to nontreated sample for each separate experiment. Each bar represents the mean SEM from at least three
independent experiments.
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of campto treatment and coincides with death commitment
(Keramaris et al., 2000; Morris et al., 2001). This suggested that
the conserved mitochondrial pathway acts downstream of Cit-
ed2. Bax and Apaf-1 are both critical for neuronal death and
caspase activation induced by DNA damage (Xiang et al., 1998;
Fortin et al., 2001). Importantly, deficiency of either gene did not
alter the induction of Cited2 consistent with the upstream nature
of the Cited2 signal (Fig. 3A). Similarly, caspase inhibitor (BAF)
treatment also did not inhibit Cited2 induction (Fig. 3B). To
confirm whether Cited2 was upstream of the mitochondrial
pathway of death, we examined the levels of mitochondrial cyt c
release after campto treatment in Cited2-deficient neurons com-
pared withWT littermates. Cited2 deficiency significantly inhib-
its mitochondrial cyt c release (Fig. 3C) after DNA damage. To
ensure that the observed effects of Cited2 deficiency were not
attributable to basal differences in mitochondrial content be-
tween KO Cited2 and WT neurons, we examined for levels of
mitochondrial markers, cyt c and OxPhos mitochondrial com-
plex I subunit. As shown in Figure 3D, top, no significant differ-
ences were found in cyt c message as measured by RT-PCR be-
tween the two genotypes. In addition, Western blot analyses also
showed no differences in cyt c and OxPhos mitochondrial com-
plex I subunit, suggesting that Cited2-deficient neurons havemi-
tochondria levels similar toWTcells (Fig. 3D, bottom). Together,
these results indicate that Cited2 induction is upstream of the
conserved mitochondrial death pathway.
The c-Jun N-terminal kinase (JNK) pathway has also been
implicated as important for DNA damage-induced death. We
showed previously that the potent MLK inhibitor CEP11004
blocked the JNK/c-Jun pathway and protected neurons from
death (Ghahremani et al., 2002). However, JNK inhibition also
failed to significantly affect Cited2 induction at early time points
(Fig. 3B). In contrast, at later time points (8 h), there did appear
to be some effect with JNK inhibition. Therefore, although there
was some modulatory effect of the JNK pathway on Cited2 late
induction, it did not appear to be the major pathway regulating
Cited2.
We mentioned above the relevance of the p53 pathway as a
required proapoptotic signal after DNA damage in neurons. p53
activation can be detected as early as 2 h (Morris et al., 2001),
making it a possible candidate as a Cited2 regulator. However,
deficiency of p53 gene did not alter the induction of Cited2 sug-
gesting that the Cited2 signal was independent of p53 (Fig. 3E).
DNA damage-Cited2 induction is regulated by Cdk4 activity
One of the earliest signals that changes after exposure to DNA
damaging agent is cyclin D1-associated activity. We previously
showed that this pathway is activated as early as 0.5–1 h after
DNA damage (Park et al., 1998). To test whether the Cdk path-
way might be important, we first examined the effects of treat-
ment with the potent Cdk inhibitor flavopiridol. This general
Cdk inhibitor protects neurons from campto-induced death as
well as blocks downstream targets of the Cdks such as the Rb
protein (Park et al., 1997a). Importantly, flavopiridol treatment
blocked the induction of Cited2 mRNA (Fig. 4A,C) and protein
(our unpublished data).
Because of potential nonspecific effects of flavopiridol, we also
determined whether expression of a kinase-dead dominant-
negative form of Cdk4 (DNCdk4), which we also reported blocks
neuronal death (Ghahremani et al., 2002), inhibits induction of
Cited2. DNCdk4 was targeted to the culture via viral-mediated
delivery. As shown in Figure 4, B andC, DNCdk4 expression also
significantly blocked Cited2 induction. Remarkably, unlike fla-
vopiridol, DNCdk4 has no effect on basal Cited2 levels (no sig-
nificant difference between untreated control and infected cells; p
value, 0.936). This suggests that Cdk4 specifically mediates the
induction of Cited2 under genotoxic conditions. The reason why
flavopiridol affects basal levels of Cited2 in addition to its induc-
tion is unknown but may be attributable to non-Cdk4-mediated
effects (other Cdks, other nonspecific effects). Nevertheless, our
results are consistent with the notion that Cdk4 is critical for the
upregulation of Cited2 after camptothecin-induced DNA
damage.
Cited2-mediated death does not involve Bmi-1, p53,
or HIF1-
We next determine how Cited2 may regulate death after DNA
damage. Previous reports suggest that Cited2 stimulates pro-
liferation by induction of Bmi-1 that in turn represses the
INK4/ARF locus of cell cycle inhibitors (Kranc et al., 2003).
We hypothesized that, in our model, Cited2 would be a signal
activated by Cdk4 to ensure its own level of activation and that
Figure2. Cited2 overexpression promotes neuronal death,whereas Cited2deficiency promotes survival after DNAdamage.A, Seventy-two to 96h after plating, cortical neuronswere transiently
cotransfectedwith emptypcDNA3orpcDNA3-Cited2andpEGPFusing calciumphosphate. Twenty-four hours after, 10Mcamptowasaddedand incubated for 21h followedby fixationandHoechst
33258 staining. Left, Photomicrographs of alive or dead cortical neurons under green fluorescence, showingGFP-transfectedneurons andHoechst-stainednuclei. At least 250GFP-positive nuclei per
treatment were assessed. Scale bar, 50m. Right, Quantitation of death induced by Cited2 expression. Percentage survival was calculated as percentage of live over total GFP-expressing neurons.
Data represent themean SEM from three replicas/treatment. ***p 0.001.B, Cortical neurons from littermate embryos derived frommultiple heterozygous Cited2mice crosses were cultured
independently and treatedwith 10M campto for 12, 16, or 24has indicated. Cellswere lysed and thenumber of survivingneuronswas evaluated. Percentage survivalwas calculated as thenumber
of live neurons in campto-treated compared with untreated control for each embryo. Each bar represents the mean SEM from n embryos as indicated. **p 0.01; ***p 0.001; N.S., no
significant difference.
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this would occur through Bmi-1 induction by Cited2. Indeed,
our results using RT-PCR show that Bmi-1 message is slightly
induced (1.5-fold) after DNA damage (Fig. 5A). This also
confirmed results in our original gene array screen (our un-
published data).
To test the hypothesis that Bmi-1may be a downstream signal
of Cited2 to mediate death after DNA damage, Bmi-1 expression
levels were analyzed by RT-PCR in pres-
ence or absence of endogenous Cited2.
However, no differences were observed
between Cited2-deficient and WT neuro-
nal cultures (Fig. 5A). This indicates that,
although Bmi-1 message levels are
changed after DNA damage, this is not rel-
evant for a Cited2-induced pathway of
death.
It has been reported that p53 is onema-
jor player in neuronal DNA damage-
induced apoptosis (Morris et al., 2001;
Aleyasin et al., 2004; Vaughn and Desh-
mukh, 2007). Additionally, we previously
showed that there appears to be cross talk
between Cdk4/6 and p53 apoptotic path-
ways (Morris et al., 2001). Here, we ex-
plored the possibility of Cited2 being part
of the cross talkmechanisms. To assess the
consequences of Cited2 deficiency on p53
activity, we looked at the profile of induc-
tion of two known p53 targets in ourmod-
el: PUMA and Noxa (Aleyasin et al., 2004;
Cregan et al., 2004), in the presence or ab-
sence of endogenous Cited2 (Fig. 5B). In
this case, as well as with Bmi-1, Cited2 de-
ficiency does not appear to inhibit the in-
duction of these two genes when com-
pared with WT littermates. This suggests
that Cited2 mechanism of death does not
include p53 activation.
Cited2 has also been reported to reg-
ulate and be regulated by HIF1- (Bhat-
tacharya and Ratcliffe, 2003; Freedman
et al., 2003). Importantly, Cited2 defi-
ciency has been shown to result in in-
creased message of HIF1--responsive
genes in the heart (Yin et al., 2002). In-
terestingly, a recent report suggests that
HIF1- expression protects hippocam-
pal neurons (HT22) against DNA dam-
age (Aminova et al., 2005). Accordingly,
we wanted to examine whether the pro-
tection conferred by Cited2 deficiency
was related to differences in HIF1- lev-
els. Using RT-PCR and Western blot, we
looked at the basal levels of HIF1- in
the brain and cultured cortical neurons
of embryos from Cited2 heterozygous
crosses. As shown in Figure 5C, top, we
did not find any differences on HIF1-
transcript levels in the brain of KO ver-
sus WT embryos. Moreover, cortical
neurons treated with DNA damage show
decreased HIF1- transcripts (our un-
published data). Interestingly, HIF1-
protein levels did not appear to differ either between Cited2
KO and WT littermates (Fig. 5C, bottom). These data suggest
that Cited2 deficiency is not protective simply because it leads
to upregulation of basal HIF1-. This result would be consis-
tent with previous reports that show that HIF1- haploinsuf-
ficiency, contrary to what happens in heart, does not rescue
brain defects in Cited2 KO embryos (Xu et al., 2007).
Figure 3. Cited2 early upregulation is upstream of themitochondrial apoptotic pathway and upstream or independent of the
JNKs and p53 pathways. A, BAX or Apaf-1 deficiency does not alter Cited2 upregulation. Cortical neurons derived from heterozy-
gous breeding of BAX or Apaf-1 transgenicmicewere cultured and treatedwith 10M campto for 2, 4, and 8 h as indicated. Total
RNAwas extracted and subjected to RT-PCR for Cited2 transcript. Results from representative embryos are presented.B, Caspases
or JNK inhibition does not affect early Cited2 upregulation. Total mRNA was extracted from cortical neurons treated for the
indicated times with campto and/or caspases inhibitor (50 M BAF) or MLK inhibitor (200 nM CEP11004). Left, Results of one
representative experiment. Right, Normalized densitometry data from at least three independent experiments. Each bar repre-
sents the mean SEM. **p 0.01; N.S., no significant difference. C, Cited2 deficiency inhibits mitochondrial cyt c release.
Cortical neurons from littermate embryos derived from heterozygous Cited2 mice crosses were cultured as independent experi-
ments and campto-treated for 12 h, followed by fixation and cyt c/Hoechst 33258 staining. Quantitation is presented as percent-
age of neurons positive for punctate cyt c. Data represent the mean SEM from three embryos of each specified genotype.
***p 0.001. D, Markers of mitochondria do not differ between Cited2 KO and WT neurons. Total mRNA from brains (top) or
protein from cortical neurons (bottom) derived from embryos from heterozygous Cited2mice crosses were analyzed as indicated
formitochondrialmarkers by RT-PCR orWestern blot.mRNA results are normalized to S12 as control andWesterns are normalized
to actin. Bars represent the mean SEM from n embryos. N.S., No significant difference. E, p53 deficiency does not alter Cited2
upregulation. WT or p53-deficient littermate cortical neurons were treated with 10M campto for 4 h. Total RNA was extracted
and subjected to quantitative RT-PCR for Cited2 transcript. Quantitative data from four embryos of specified genotype are pre-
sented as fold increase compared with untreated control for each embryo. The bars represent the mean SEM. N.S., No signifi-
cant difference.
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Cited2-mediated death occurs via
PPAR activation
Interestingly, Cited2 is known to be able to
act as a ligand-independent coactivator of
PPAR (Tien et al., 2004). The role of
PPAR in neuronal death induced by
DNA damage is unclear. Accordingly, we
first determined whether PPAR might
play a role in our systemof neuronal death.
As shown in Figure 6A, GW9662, a spe-
cific, potent, and irreversible antagonist of
PPAR (Leesnitzer et al., 2002), signifi-
cantly delayed death at 10–30 M concen-
trations. In addition, caspase 3 activation
normally observed after DNA damage
(Stefanis et al., 1999; Morris et al., 2001)
was significantly decreased after treatment
with the GW9662 inhibitor (Fig. 6B).
The above experiments indicate that
PPAR blockers delay death induced by
campto treatment. If our model that Cit-
ed2 signals death through PPAR were
true, we would anticipate that death in-
duced by direct Cited2 expression would
also be blocked by GW9662. As shown in
Figure 6C, this antagonist significantly in-
hibited the death induced by both Cited2
expression alone as well as with campto/
Cited2 cotreatment. Finally, consistent
with the model that the Cited2-mediated
signal acts upstream of the mitochondria,
GW9662 treatment also blocked cyt c re-
lease (Fig. 6D).
We also explored the converse effects of
PPAR activation by ciglitazone, a PPAR
agonist (Willson et al., 1996), on death of
cortical neurons. As shown in Figure 7A,
ciglitazone induces death of cortical neu-
rons even in the absence of DNA damage,
supporting the notion that PPAR activa-
tion can act as a death effector. Ciglitazone
treatment also did not appear to further
increase campto-induced death (Fig. 7B).
Because ciglitazonemay have other targets
other than PPAR, we examined whether
the death-promoting effect of ciglitazone
was dependent on PPAR. Expression of a
double mutant (L468A/E471A) form of
PPAR has been shown to be a potent
dominant-negative inhibitor of wild-type
PPAR activity (Gurnell et al., 2000). Ac-
cordingly, we first show that expression of
DNPPAR blocks death of cortical neu-
rons exposed to DNA damage (Fig. 7C).
This supports the protection observed
with pharmacological inhibition of
PPAR. Second, DNPPAR expression
also blocked death caused by ciglitazone
supporting the specificity of the agonist.
Interestingly, we show that death induced by ciglitazone is actu-
ally dependent onCited2 (Fig. 7D). Thiswould be consistentwith
the notion that Cited2 is required coactivator of PPAR to induce
death.
To further support the importance of PPAR, we next deter-
mined whether its activity is induced after DNA damage. To do
this, we used a reporter system, which consisted of luciferase
expressed under the regulation of a PPAR-responsive element
Figure 4. Cited2 upregulation is blocked by Cdk4 inhibition. A, Cortical neurons were treated with campto and/or 1 M
flavopiridol. Total RNA was extracted at indicated times and submitted to RT-PCR. Image from one representative experiment is
shown.B, Downregulation of endogenous Cdk4 activity inhibits Cited2upregulation. Cortical neuronswere infectedwith 150MOI
of DNCdk4 or GFP control expressing AAV as indicated inMaterials andMethods. After 6–7DIV, neuronswere treatedwith 10M
campto for indicated times. Total RNA or protein was extracted and submitted to RT-PCR (top) or Western blot (bottom). Images
show results from one representative experiment. C, Normalized RT-PCR densitometry data from flavopiridol and DNCdk4 exper-
iments are presented as fold increase relative to nontreated sample. Each bar represents the mean SEM from at least three
independent experiments. *p 0.05; N.S., no significant difference.
Figure 5. Cited2 deficiency does not affect Bmi-1 upregulation, p53 activity, or basal HIF1- levels. A, B, Embryonic cortical
neurons derived from heterozygous Cited2 crosses were independently cultured and treated with 10M campto as indicated.
Total RNA was extracted and subjected to RT-PCR for Bmi-1, PUMA, Noxa, and S12. A, Top, RT-PCR results from representative
embryos. Signals were analyzed by densitometry and Bmi-1 signal was normalized using S12. Bottom, Data are presented as fold
increase relative to nontreated sample for each embryo. Each bar represents themean SEM for n embryos.B, RT-PCR results for
PumaandNoxa transcripts from representative embryos.C, Quantitation ofHIF1-basal levels. The toppanel showsmRNA levels
in whole brains from littermates embryos from heterozygous Cited2 crosses. Data are presented as normalized values relative to
S12 signal for each embryo. The bottom panel shows protein results from independently cultured cortical neurons from litter-
mates embryos from heterozygous Cited2 crosses. Data are presented as normalized values relative to actin signal for each
embryo. The bars represent the mean SEM from n embryos of specified genotype. N.S., No significant difference.
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(PPRE-luciferase). As shown in Figure 8A, PPAR activity is up-
regulated after DNA damage, with a peak 3 h after initiation of
campto exposure (Fig. 8D). This induction was inhibited by the
Cdk inhibitor flavopiridol, consistent with the model that Cdks
are upstream regulators of PPAR (Fig. 8A). The induction of
PPAR activity could not be accounted for by upregulation of
PPAR levels. In fact, PPAR mRNA levels appear to decrease
after DNA damage (Fig. 8B). PPAR protein was also not signif-
icantly elevated after campto exposure (Fig. 8C). We also exam-
ined another PPAR family member with the potential to be acti-
vated by Cited2, PPAR. Its protein level
was not significantly altered after DNA
damage (our unpublished data).
To test whether PPAR activation after
DNA damage is Cited2 dependent, we
measured PPAR reporter activity after
DNA damage in cultured neurons derived
from Cited2-deficient cultures or WT lit-
termate controls (Fig. 8D). We found that
Cited2 deficiency significantly blocked the
upregulation of PPAR activation. Impor-
tantly, the basal level of PPAR activity
was not different betweenCited2-deficient
and WT neurons (Fig. 8E).
If Cited2 was critical for PPAR activa-
tion, we would predict that exogenous ex-
pression of Cited2 in neurons would in-
duce PPAR activity, similar to DNA
damage. Indeed, we found this to be the
case. As shown in Figure 8F, Cited2 ex-
pression alone caused an induction of
PPAR reporter activity similar to that of
campto treatment (Fig. 8A).
Finally, if Cited2 acts as a coactivator of
PPAR (Tien et al., 2004), we would antic-
ipate that they should interact. We exam-
ined this possibility in neurons untreated
and treated with campto by IP/Western
blot analyses. In this experiment, Cited2
was immunoprecipitated from cell ex-
tracts untreated or treated with campto
followed by Western blot analyses for
PPAR. As shown in Figure 8G, we de-
tected very little basal interaction between
Cited2 and PPAR. However, significant
interaction was observed after treatment
with campto. The above data suggest that
Cited2 is required for DNA damage-
induced PPAR activation and subse-
quent cell death.
Together, these results present a model
by which Cdk4-mediated induction of
Cited2 leads to activation of PPAR,
caspase activation, and consequent neuro-
nal death.
Discussion
Integrity and fidelity of DNA is essential
for the proper function and survival of
neurons. However, our understanding of
the complex signals that govern neuronal
death after DNA damage is incomplete.
We previously showed that cell cycle Cdks
as well as p53 regulate the mitochondrial
pathway of death (Morris et al., 2001). We presently provide
additional critical insight into signals that participate in DNA
damage-induced death. Our results indicate that Cited2 is upregu-
lated in a manner dependent on the cell cycle Cdk4 pathway, up-
stream of themitochondrial pathway. Importantly, we also provide
data that indicate a proapoptotic role for Cited2 and that Cited2
promotes death through direct activation of PPAR. Together, our
results define a unique Cdk4–Cited2–PPAR-mediated pathway
that regulates DNA damage-induced neuronal death.
Figure 6. Effects of PPAR inhibition with GW9662. A, GW9662 protects cortical neurons from DNA damage. After 4 DIV,
cortical neurons were treated with 10M campto alone or together with GW9662 at various concentrations (10–30M). Cells
were lysed and intact nuclei were counted as described in Materials and Methods. The top panel quantifies neurons treated with
camptoandGW9662whencomparedwithuntreated controls. Percentage survivalwas calculatedas thenumberof remaining live
nuclei in treated wells compared with completely untreated cultures. The middle panel quantifies neurons treated only with
GW9662. Percentage survival was calculated as the number of remaining live nuclei in treated wells compared with completely
untreated controls. The bottom panel shows values when neurons treated with campto and GW9662 are compared with those
formneurons treatedonlywithGW9662. Thebars represent themeanSEM fromat least three independent experiments. *p
0.05; **p 0.01; ***p 0.001; N.S., no significant difference.B, GW9662 inhibits caspase activation induced by DNA damage.
Cortical neurons were treated with campto alone or together with 20M GW9662 for 16 h. Protein was extracted as described in
Materials and Methods, and caspase activity was determined in triplicate as the slope of linear regression (fluorescence vs time
plot) for each replica. Each bar represents the mean SEM from four independent experiments. **p 0.01. C, Cited2-induced
death of cortical neurons is inhibited by GW9662. Seventy-two to 96 h after plating, cortical neurons were transiently cotrans-
fectedwith empty pcDNA3 or pcDNA3-Cited2 and pEGPF using Lipofectamine. Twenty-four hours after, 10M campto and/or 20
M GW9662was added and incubated for 21 h followed by fixation and Hoechst 33258 staining. At least 100 GFP-positive nuclei
per treatment were assessed. Percentage survival was calculated as percentage of live over total GFP-expressing neurons. Data
represent the mean SEM from three independent experiments. ***p 0.001. D, GW9662 blocks cytochrome c release from
the mitochondria after DNA damage. Cortical neurons were cultured and treated with campto and/or 20M GW9662 for 12 h,
followedby fixationandcyt c/Hoechst 33258 staining.Quantitation is presentedaspercentageofneuronspositive forpunctate cyt
c. Data represent the mean SEM from three independent experiments. ***p 0.001.
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Prodeath role of Cited2
The role of Cited2 in neuronal death had
never before been examined.Nevertheless,
a number of correlational observations
have suggested that Cited2might be some-
how linked to neuronal survival (Sun et al.,
2007). For example, 57% of Cited2 KO
embryos exhibit enhanced apoptosis of
midbrain cells (Bamforth et al., 2001). Cit-
ed2 upregulation could be detected by in
situ hybridization in the hippocampus af-
ter global ischemia, but predominately, in
areas which are spared (dentate gyrus)
rather than injured (CA1) (Sun et al.,
2006). These observations suggested that
Cited2 might be functioning as a prosur-
vival gene to inhibit neuronal death. How-
ever, alternative explanations for these ob-
servations could be provided. As one
example, death of midbrain cells in Cited2
KO embryos could be a non-cell-
autonomous event caused by other
defects.
Presently, we confirm an increase in
Cited2 levels in cultured neurons after
DNA damage. More importantly, we
present direct evidence that define, for the
first time, the role of Cited2 in neuronal
death/survival. Unlike previous sugges-
tions, we show that Cited2 plays a pro-
apoptotic role after DNA damage. Our ev-
idence is as follows: (1) Cited2 message
and protein are increased at early stages
after insult, (2) exogenous expression of
Cited2 promotes neuronal death, and (3)
Cited2 deficiency significantly delays
death after DNA damage. Whether Cited2 functions similarly in
other neuronal injury paradigms is unknown. However, we ob-
served similar increases of Cited2 message in the CA1 region of
the hippocampus of rats after global ischemia (our unpublished
data). This suggests the possibility that Cited2may also play a role
in neuronal death under other contexts. It is important to em-
phasize that Cited2 deficiency is only partially protective. This is
consistent with the notion that multiple signals act in concert to
regulate neuronal death after DNA damage (Morris et al., 2001;
Ghahremani et al., 2002; Keramaris et al., 2003; Sedarous et al.,
2003; Aleyasin et al., 2004).
Mechanism for Cited2 upregulation
Our present studies also begin to define the pathway by which
Cited2 is induced. Our results indicate that the early increase in
Cited2 message is not attributable to several critical signals we
previously established to be important in this paradigm of death.
These include (1) the mitochondrial pathway of death (Putcha et
al., 1999; Keramaris et al., 2000; Cregan et al., 2002), (2) p53
(Morris et al., 2001; Vaughn andDeshmukh, 2007), and (3) JNKs
(Ghahremani et al., 2002; Besirli and Johnson, 2003). Instead, our
studies reveal that Cdk4 activity is critical for early Cited2 induc-
tion. We previously showed that cyclin D1-associated Cdks
(Cdk4/6) are aberrantly activated in neurons after DNA damage
(Park et al., 1998) and various different in vitro neuronal death
paradigms (Park et al., 1996, 1997b; Giovanni et al., 1999; Pad-
manabhan et al., 1999; Rideout et al., 2003). This evidence also
extends to in vivo injury and neurodegenerative contexts includ-
ing after stroke/ischemia (Osuga et al., 2000), Alzheimer’s disease
(McShea et al., 1997; Biswas et al., 2007), and amyotrophic lateral
sclerosis (Nguyen et al., 2003). We and others have shown that
Cdk4/6 activity is essential to signal death in many paradigms of
neuronal apoptosis, including after DNAdamage in vitro (Park et
al., 1998;Morris et al., 2001; Zhang et al., 2006) and stroke in vivo
(Rashidian et al., 2005). Moreover, classic downstream targets of
Cdk4, Rb, and E2F, have also been shown to be critical for neu-
ronal death. We and others showed that Cdk4 regulates the ac-
tivity of Rb by phosphorylation and its subsequent inactivation,
and so releasing E2F transcription factors from inactivity (Gio-
vanni et al., 2000; Park et al., 2000; Gendron et al., 2001). E2F
activation in turn induces the upregulation of proapoptotic
genes, such as B- and C-myb (Liu et al., 2004; Biswas et al., 2005;
Greene et al., 2007).
What is the link between cell cycle activation and Cited2?
Cited2 has been linked to cell transformation (Sun et al., 1998;
Chou and Yang, 2006; Haase et al., 2007). Additionally, Cited2
overexpression enhances fibroblast proliferation and Cited2 de-
ficiency prematurely stops proliferation. It was proposed that
Cited2 stimulates proliferation by induction of Bmi-1 that in turn
represses the INK4/ARF locus of cell cycle inhibitors (Kranc et al.,
2003). In the context of our present work, this suggested the
intriguing connection that cell cycle may be activated by Cited2
expression through induction of Bmi-1. However, our results
show that, although Bmi-1 is induced after DNAdamage, it is not
Figure 7. Ciglitazone, a PPAR agonist, induces death of cortical neurons in amanner dependent on Cited2 activity.A, After 4
DIV, cortical neurons were treated with various concentrations (20–50M) of ciglitazone. Cells were lysed at the specified time
points and intact nucleiwere counted as described inMaterials andMethods. Percentage survivalwas calculated as the number of
remaining live nuclei in treated wells compared with untreated control. The bars represent the mean SEM from at least three
independent experiments. ***p 0.001.B, Ciglitazone does not enhance campto-induced death. Cortical neuronswere treated
for 16 h with 1 or 10M campto alone or together with ciglitazone (20–50M). Cells were lysed and processed as described
above. The bars represent the mean SEM from at least three independent experiments. N.S., No significant difference. C,
Expression of dominant-negative PPAR protects neurons from ciglitazone-induced and campto-induced death. Seventy-two to
96 h after plating, cortical neurons were transiently cotransfected with empty pcDNA3 or pcDNA3-DNPPAR and pEGPF using
Lipofectamine. Twenty-four hours after, 10 M campto or 40 M ciglitazone was added and incubated for 21 h followed by
fixation and Hoechst 33258 staining. At least 100 GFP-positive nuclei per treatment were assessed. Percentage survival was
calculated as percentage of live over total GFP-expressing neurons. Data represent the mean SEM from three independent
experiments. ***p 0.001.D, Cited2 deficiency completely inhibits ciglitazone-induced death. Cortical neurons from littermate
embryos derived from heterozygous Cited2 mice crosses were cultured as independent experiments and treated with 40 M
ciglitazone for 16 h. Cells were lysed and number of surviving neurons was evaluated. Percentage survival was calculated as the
number of live neurons after treatment compare with untreated control for each embryo. Each bar represents the mean SEM
from three embryos. ***p 0.001.
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regulated by Cited2. This indicates that it is unlikely that Cited2
acts upstream of Cdk4 activation.
In contrast, our present data point out that inhibition of Cdk4
blocks Cited2 induction suggesting that Cited2 is a downstream
target of Cdk4. Whether Cdk4 regulation
of Cited2 is through the classic Rb/E2F
pathway described above is unknown. A
search of mouse Cited2 promoter using
TRANSFAC software (version4.0-
database7-publicI) and Genomatix/
Gene2Promoter analysis both revealed no
clear consensus binding sites for E2F,
C-myb, or B-myb. However, the same
search exposed an AP-1 putative interact-
ing site (	1110 to	1101). In this regard,
c-Jun has been shown to interact with the
Cited2 promoter in human proliferating
cells (Hayakawa et al., 2004). Intriguingly,
our previous work in our model of DNA
damage-induced neuronal death indicated
that c-Jun activation was dependent on
Cdk4 activation (Ghahremani et al., 2002)
as well as the classic upstream JNK family
members. Our present results indicate that
JNKs only partially regulate Cited2 induc-
tion and at late times, whereas Cdk4 more
robustly regulated Cited2 levels. This is
identical with that we previously reported
for regulation of c-Jun. This suggests the
possibility of Cited2 being a c-Jun target
after DNA damage. However, more care-
ful analyses will have to be performed to
clarify this issue.
Mechanism for Cited2-mediated death
Our present results indicate that one im-
portant mechanism by which Cited2 pro-
motes death is through regulation of
PPAR. PPAR is a complex signal with
both proapoptotic (Rohn et al., 2001) as
well as protective functions (Arnold and
Konig, 2006; Collino et al., 2006). The role
of PPAR likely depends on the context of
the cell or model system. For example,
PPAR is known to regulate neuroinflam-
mation by inhibiting microglial activation
(Bernardo and Minghetti, 2006). In this
context, PPAR activation strategies
would be expected to promote survival
under contexts in which inflammation is a
critical component of injury. However,
PPAR activation is also able to promote
death of multiple cell types including neu-
rons (Zhang et al., 2005).
Our findings indicate that PPAR par-
ticipates in the death of neurons afterDNA
damage. This is supported by the follow-
ing: (1) PPAR activity is increased after
DNA damage, (2) inhibition of PPAR ac-
tivation through multiple means pro-
motes survival, and (3) PPAR agonist can
induce death. Importantly, we also show
that the upregulation of PPAR activity is
dependent on Cited2 and that PPAR is a critical mediator of
Cited2-induced death. This notion is substantiated by the obser-
vations that (1) Cited2 expression is sufficient to activate PPAR
and Cited2 deficiency inhibits DNA damage-induced PPAR ac-
Figure 8. PPAR activity, but not levels, is upregulated after DNA damage in a Cdk-Cited2-dependent manner. A, PPAR
activity increases after DNA damage and is blocked by the Cdk inhibitor flavopiridol. Seventy-two hours after plating, cortical
neurons were transiently cotransfected with PPRE-luciferase- and CMV--galactosidase-expressing plasmids using Lipo-
fectamine as described in Materials and Methods. Twenty-four hours after, cells were treated with 10M campto and/or 1M
flavopiridol for specified times. Data represent values of luciferase/-galactosidase activity. Bars represent themeanSEM from
four independent experiments. ***p 0.001. B, PPARmessage decreases after DNA damage. Cortical neurons were treated
with campto at indicated times. Total RNAwas extracted and RT-PCR result fromone representative experiment is shown in inset.
Normalized densitometry data are presented as fold change relative to nontreated sample. Each bar represents themean SEM
from three independent experiments. C, Total protein was extracted from campto-treated cortical neurons and analyzed by
Western blot as described. Results from one representative experiment are shown. D, Cited2 deficiency blocks PPAR activity
upregulation by campto. Seventy-two hours after plating, cortical neurons from littermate embryos from heterozygous Cited2
crosses independently cultured were transfected and treated with 10M campto to assess PPAR activity as described above.
Values represent fold change of normalized luciferase activity (luciferase/-galactosidase) of correspondent sample relative to
transfected nontreated sample. Each bar represents the mean SEM from n embryos. *p 0.05. E, Basal PPAR activity does
not differ between Cited2 KO and WT neurons. PPAR activity was measured as described in D and presented as normalized
luciferase activity (luciferase/-galactosidase). The bars represent the mean SEM from n independently cultured embryos.
N.S., No significantdifference.F, Cited2overexpression inducesPPARactivity. Seventy-two to96hafter plating, cortical neurons
were transiently cotransfected with empty pcDNA3 or pcDNA3-Cited2-, PPRE-luciferase-, and CMV--galactosidase-expressing
plasmids using Lipofectamine. Twenty-four hours after, luciferase activity was evaluated as described in Materials and Methods.
Data are presented as normalized luciferase activity (luciferase/-galactosidase). Each bar represents the mean SEM from
three independent experiments. ***p 0.001. G, Cited2 and PPAR interact after DNA damage. Cortical neurons were treated
with campto at indicated times and total protein was extracted as indicated in Materials andMethods. Control IgG or anti-Cited2
antibodies were incubated with total cell lysates (2 10 7 neurons). Antibodies were isolated by IP beads and resolved by
SDS-PAGE followed by anti-PPARWestern blot. Results from two independent experiments are shown. Inp., Input, TCA precip-
itate from total cell lysate (10 7 untreated neurons).
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tivation, (2) PPAR inhibition blocks Cited2-mediated death,
and (3) Cited2 deficiency inhibits death induced by PPAR ago-
nist. The latter two points also suggest that both Cited2 and
PPAR require each other to induce death. It must be noted that
we do not knowwhether Cited2-mediated activation of PPAR is
direct.However, our results show that PPAR activation could be
accounted for by increase in Cited2 levels, because Cited2 up-
regulation at 2 h after campto is already significant.Moreover, we
see an early increase in an interaction between PPAR andCited2
as revealed by IP/Western blot, suggesting a more direct mecha-
nism of action.
Our work defines, for the first time, the circumstances of Cit-
ed2 as a proapoptotic signal in neurons (Fig. 9). It is not known
whether Cited2 may also play similar roles in adult contexts of
neuronal injury such as with stroke. However, it is important to
point out that similar players such as cell cycle signals are also
critical in adultmodels of injury (Rashidian et al., 2005).Whether
Cited2, then, mediates the prodeath function of cell cycle signals
in ischemic death will be an intriguing area of future study.
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